missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18654893

CD14 Antibody (2551F) [FITC], Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals FAB10461F

Product Code. 18654893

  • € 553.00 / 0.10mL
Define Immunology Research on Your Terms With R&D Systems
Use promo code 24090
View all promotions

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD14 Monoclonal antibody specifically detects CD14 in Human samples. It is validated for Flow Cytometry, Neutralization, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD14
Monoclonal
FITC
PBS
Rabbit
Protein A or G purified from cell culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, Neutralization, CyTOF
2551F
Flow Cytometry, Neutralization, CyTOF-ready
CD14 antigen, CD14 molecule, monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein
Chinese hamster ovary cell line CHO-derived recombinant human CD14, Thr20-Cys352, Accession # P08571
0.1 mL
Adaptive Immunity, Apoptosis, Asthma, Biologically Active Proteins, Cancer, Cell Biology, Cytokine Research, Immunology, Innate Immunity, Myeloid Cell Markers, Stem Cell Markers
929
Store at 4°C in the dark.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.